布美他尼调节STING/TBK1/IRF3信号通路对急性胰腺炎大鼠炎症损伤的影响OA
Effect of bumetanib on inflammatory injury in rats with acute pancreatitis by regulating STING/TBK1/IRF3 signaling pathway
目的:探究布美他尼调节干扰素基因刺激因子(STING)/TANK结合激酶1(TBK1)/转录因子干扰素调节因子3(IRF3)信号通路对急性胰腺炎(AP)大鼠炎症损伤的影响.方法:Wistar大鼠采用雨蛙素联合脂多糖建立AP模型,随机分为AP组、布美他尼低剂量组、布美他尼高剂量组、布美他尼高剂量+DMXAA组,每组10只,另取10只Wistar大鼠设为对照组,用布美他尼和STING激活剂DMXAA分组干预后检测各组大鼠血清淀粉酶和脂肪酶活性;HE染色检测各组大鼠胰腺组织病理形态;免疫组化染色检测各组大鼠胰腺组织CD68表达,评估其巨噬细胞浸润情况;ELISA检测各组大鼠促炎因子水平;Western blot检测各组大鼠胰腺促炎因子与STING/TBK1/IRF3信号通路蛋白表达.结果:相比于对照组,AP组大鼠胰腺组织具有明显病理损伤症状,血清淀粉酶和脂肪酶活性、病理损伤评分、巨噬细胞浸润数、TNF-α、iNOS与IL-6水平、TNF-α、iNOS、IL-6、STING、TBK1与IRF3蛋白表达明显升高(P<0.05);相比于AP组,布美他尼低、高剂量组大鼠胰腺组织病理损伤症状均减轻,血清淀粉酶和脂肪酶活性、病理损伤评分、巨噬细胞浸润数、TNF-α、iNOS及IL-6水平、TNF-α、iNOS、IL-6、STING、TBK1与IRF3蛋白表达降低(P<0.05),高剂量布美他尼作用更强;相比布美他尼高剂量组,布美他尼高剂量+DMXAA组大鼠胰腺组织病理损伤症状加重,血清淀粉酶和脂肪酶活性、病理损伤评分、巨噬细胞浸润数、TNF-α、iNOS及IL-6水平、TNF-α、iNOS、IL-6、STING、TBK1及IRF3蛋白表达升高(P<0.05).结论:布美他尼可通过抑制STING/TBK1/IRF3信号通路激活阻止AP大鼠全身及胰腺组织炎症发生发展,进而减轻其炎症损伤.
Objective:To investigate effect of bumetanib on inflammatory injury in acute pancreatitis(AP)rats by regulating the stimulator of interferon gene(STING)/TANK binding kinase 1(TBK1)/interferon regulatory factor 3(IRF3)signaling pathway.Methods:Wistar rats were used to establish an AP model by combining Caerulein with lipopolysaccharide,which were grouped into an AP group,a low-dose bumetanib group,a high-dose bumetanib group and a high-dose bumetanib+DMXAA group randomly,with 10 rats in each group.Another 10 Wistar rats were included as control group.After intervention with bumetanib and STING activator DMXAA,serum amylase and lipase activities were detected in each group.HE staining was used to detect the pathological morphology of pancreatic tissue in each group.Immunohistochemical staining was applied to detect the expression of CD68 in pancreatic tissue of rats in each group and the infiltration of macrophages was evaluated based on this.ELISA was used to detect the levels of pro-inflamma-tory cytokines in each group.Western blot was used to detect the expression of pro-inflammatory cytokines and STING/TBK1/IRF3 sig-naling pathway proteins in the pancreas of rats in each group.Results:Compared with control group,the pancreatic tissue of rats in AP group showed obvious pathological damage symptoms,the serum amylase and lipase activities,pathological injury score,macrophage infiltration number,TNF-α,iNOS and IL-6 levels,TNF-α,iNOS,IL-6,STING,TBK1 and IRF3 protein expressions were obviously increased(P<0.05).Compared with AP group,the pathological damage symptoms of pancreatic tissue of rats in low and high dose bu-metanib groups were reduced,the serum amylase and lipase activities,pathological injury score,macrophage infiltration number,TNF-α,iNOS and IL-6 levels,TNF-α,iNOS,IL-6,STING,TBK1 and IRF3 protein expressions were obviously decreased(P<0.05),high-dose bumetanib had stronger effects.Compared with high-dose bumetanide group,the pathological damage symptoms of pancreatic tissue in rats in high-dose bumetanide+DMXAA group were aggravated,the serum amylase and lipase activities,patholog-ical injury score,macrophage infiltration number,TNF-α,iNOS and IL-6 levels,TNF-α,iNOS,IL-6,STING,TBK1 and IRF3 pro-tein expression were obviously increased(P<0.05).Conclusion:Bumetanib inhibits the activation of the STING/TBK1/IRF3 signaling pathway to prevent the occurrence and development of systemic and pancreatic inflammations in AP rats,thereby reducing their in-flammatory damage.
岳鹏;覃广乐;王良;张辉
淄博市第一医院急诊科,淄博 255200淄博市第一医院急诊科,淄博 255200淄博市第一医院急诊科,淄博 255200淄博市第一医院急诊科,淄博 255200
医药卫生
布美他尼STING/TBK1/IRF3急性胰腺炎炎症损伤
BumetanibSTING/TBK1/IRF3Acute pancreatitisInflammatory injury
《中国免疫学杂志》 2026 (6)
1342-1347,6
评论